Hopp til hovedinnhold

Leverpåvirkning i graviditeten

Sist revidert:
Sist revidert av:
  1. Lee RH. Approach to liver disease occurring during pregnancy. UpToDate, last updated Nov 18, 2020. UpToDate  
  2. García-Romero CS, Guzman C, Cervantes A, Cerbón M. Liver disease in pregnancy: Medical aspects and their implications for mother and child. Ann Hepatol. 2019 Jul-Aug;18(4):553-562. PMID: 31126882. PubMed  
  3. Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol, 64 (2016), pp. 933-945. PMID: 26658682. PubMed  
  4. Ellington SR, Flowers L, Legardy-Williams JK, et al. Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010. Am J Obstet Gynecol 2015; 212:524.e1.
  5. Mikolasevic I, Filipec-Kanizaj T, Jakopcic I, et al. Liver Disease During Pregnancy: A Challenging Clinical Issue. Med Sci Monit. 2018;24:4080-4090. Published 2018 Jun 15. PMID: 29905165. PubMed  
  6. Jochumsen KM, Svane D, Bødker B et al. Ursodeoxycholsyre til behandling af intrahepatisk kolestase i graviditeten. Ugeskr Læger 2003; 165: 3825-8. Ugeskrift for Læger  
  7. Knight M, Nelson-Piercy C, Kurinczuk JJ, et al. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008; 57:951. Gut  
  8. Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol 2013; 209:456.e1.
  9. Reau N. Finding the needle in the haystack: predicting mortality in pregnancy-related liver disease. Clin Gastroenterol Hepatol 2014; 12:114. PubMed  
  10. Jochumsen KM, Ainsworth AP, Stolze Larsen F. Leverpåvirkning i graviditeten. Ugeskr Læger 2005; 167: 2635. PubMed  
  • Terje Johannessen, professor i allmennmedisin, Trondheim (tilpasning til NEL)